Concepedia

Margherita Passariello

MP

22

Publications

675

Citations

15

H-Index

2018

Active since

Affiliations

University of Naples Federico II(Current)

Ceinge Biotecnologie Avanzate (Italy)

Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"

European School of Molecular Medicine

University of Milan

Margherita Passariello is an author at University of Naples Federico II specializing in immunology, medicine, and immunotherapy.

ORCID

Top concepts

Publications per year

2018–2024

22

Publications

22

Aptamer targeted therapy potentiates immune checkpoint blockade in triple-negative breast cancer

Simona Camorani, Margherita Passariello, Lisa Agnello et al. · Journal of Experimental & Clinical Cancer Research · 2020 · 64 citations · Full text

Evidences of CTLA-4 and PD-1 Blocking Agents-Induced Cardiotoxicity in Cellular and Preclinical Models

Vincenzo Quagliariello, Margherita Passariello, Domenica Rea et al. · Journal of Personalized Medicine · 2020 · 64 citations · Full text

Cardiotoxicity and pro-inflammatory effects of the immune checkpoint inhibitor Pembrolizumab associated to Trastuzumab

Vincenzo Quagliariello, Margherita Passariello, Carmela Coppola et al. · International Journal of Cardiology · 2019 · 61 citations

, , +10

Novel Human Bispecific Aptamer–Antibody Conjugates for Efficient Cancer Cell Killing

Margherita Passariello, Simona Camorani, Cinzia Vetrei et al. · Cancers · 2019 · 53 citations · Full text

, , +16

Novel Human Anti-PD-L1 mAbs Inhibit Immune-Independent Tumor Cell Growth and PD-L1 Associated Intracellular Signalling

Margherita Passariello, Anna Morena D’Alise, Annachiara Esposito et al. · Scientific Reports · 2019 · 53 citations · Full text

Rows per page

1–5 of 22